1. Home
  2. IRIX

as 12-20-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Founded: 1989 Country:
United States
United States
Employees: N/A City: MOUNTAIN VIEW
Market Cap: 28.6M IPO Year: 1996
Target Price: $2.00 AVG Volume (30 days): 29.8K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.68 EPS Growth: N/A
52 Week Low/High: $1.27 - $3.65 Next Earning Date: 11-12-2024
Revenue: $48,431,000 Revenue Growth: -11.31%
Revenue Growth (this year): -2.46% Revenue Growth (next year): 5.44%

IRIX Daily Stock ML Predictions

Share on Social Networks: